These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32571126)

  • 1. Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?
    Ortiz GG; Mireles-Ramírez MA; Pacheco-Moisés FP; Ramírez-Jirano LJ; Bitzer-Quintero OK; Delgado-Lara DLC; Flores-Alvarado LJ; Mora-Navarro MA; Huerta M; Torres-Mendoza BMG
    Int J Neurosci; 2021 Dec; 131(12):1221-1230. PubMed ID: 32571126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuronal injury in multiple sclerosis].
    Correale J; Meli F; Ysrraelit C
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.
    Zeis T; Schaeren-Wiemers N
    J Mol Neurosci; 2008 May; 35(1):91-100. PubMed ID: 18278568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte-microglia cross-talk in the central nervous system.
    Peferoen L; Kipp M; van der Valk P; van Noort JM; Amor S
    Immunology; 2014 Mar; 141(3):302-13. PubMed ID: 23981039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting myelin repair and return of function in multiple sclerosis.
    Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
    FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
    Oluich LJ; Stratton JA; Xing YL; Ng SW; Cate HS; Sah P; Windels F; Kilpatrick TJ; Merson TD
    J Neurosci; 2012 Jun; 32(24):8317-30. PubMed ID: 22699912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
    Tegla CA; Cudrici C; Rus V; Ito T; Vlaicu S; Singh A; Rus H
    J Neuroimmunol; 2009 Aug; 213(1-2):3-11. PubMed ID: 19577811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocyte-Specific Deletion of
    Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelination in multiple sclerosis.
    Lubetzki C; Stankoff B
    Handb Clin Neurol; 2014; 122():89-99. PubMed ID: 24507514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
    Linden JR; Ma Y; Zhao B; Harris JM; Rumah KR; Schaeren-Wiemers N; Vartanian T
    mBio; 2015 Jun; 6(3):e02513. PubMed ID: 26081637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune promotion of central nervous system remyelination.
    Rodriguez M; Miller DJ
    Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion.
    Raine CS
    J Neuroimmunol; 1997 Aug; 77(2):135-52. PubMed ID: 9258244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination.
    Tsunoda I; Fujinami RS
    Springer Semin Immunopathol; 2002; 24(2):105-25. PubMed ID: 12503060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
    Werner P; Pitt D; Raine CS
    J Neural Transm Suppl; 2000; (60):375-85. PubMed ID: 11205156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.